GMP BIO CO., LTD.

닫기

Treg CELL THERAPY

Cell therapy composition for preventing or treating neurodegenerative disease comprising regulatory T cells as active ingredient

(Cell therapy composition for preventing or treating neurodegenerative disease comprising regulatory T cells as active ingredient)

registration number : 1018022480000 / registration date : 2017.11.22

This invention concerns the formation of a degenerative brain disease prevention or treatment cellular therapy with the efficacy of regulatory T cells, personalization kits, and the phase in which these compounds are administered to degenerative brain disease objects.

1. Experimental method
  • 01

    Cell separation and cell culture

    다음
  • 02

    Cell injection into
    Alzheimer's animal model

    다음
  • 03

    Maurice Aquarius Experiment

    다음
  • 04

    FACS analysis

    다음
  • 05

    Check the amount of inflammation-related (cytokine) expression

    다음
  • 06

    Immunostaining

2. Effect of Treg-Injected Animal Model on the Cognitive Capacity Recovery
3. Increase of Treg cells and check the expression of cytokines in spleen cells of animal model injected with Treg
4. Reducing Effect of Amyloid Beta Plaque and Microglia in Animal Models with Treg Injection
5. The Effect of Cognitive Capacity Recovery in Animal Models with Amyloid Beta specific-Treg Cells
6. Increase of Helper T cells and check the expression of cytokines in spleen cells of animal model injected with Amyloid Beta specific-Treg Cells
7. Reducing Effect of Amyloid Beta Plaque in Animal Models with Amyloid Beta specific-Treg Cells Injection
top